Figure 1 illustrates gene expression analysis of Tissue matrix metalloproteinase-2 inhibitor (TIMP2) (Figure 1A) and Matrix metalloproteinase-2 (MMP2) (Figure 1B) of patients with obesity pre- and post-operative period in PBMC. Here, MMP2 is linked to obesity disorder.